ruboxistaurin has been researched along with muraglitazar in 1 studies
Studies (ruboxistaurin) | Trials (ruboxistaurin) | Recent Studies (post-2010) (ruboxistaurin) | Studies (muraglitazar) | Trials (muraglitazar) | Recent Studies (post-2010) (muraglitazar) |
---|---|---|---|---|---|
203 | 29 | 56 | 85 | 10 | 25 |
Protein | Taxonomy | ruboxistaurin (IC50) | muraglitazar (IC50) |
---|---|---|---|
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.1867 | |
Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.22 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lebovitz, H | 1 |
1 review(s) available for ruboxistaurin and muraglitazar
Article | Year |
---|---|
Diabetes: assessing the pipeline.
Topics: Adamantane; Alkanesulfonates; Amyloid; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exenatide; Glycine; Humans; Hypoglycemic Agents; Indoles; Islet Amyloid Polypeptide; Maleimides; Nitriles; Oxazoles; Peptides; Phenylpropionates; Piperidines; PPAR alpha; PPAR gamma; Protein Kinase C; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, Glucagon; Rimonabant; Venoms; Vildagliptin | 2006 |